Synchrony Financial Q3 2024 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2024. Synchrony Financial operates as a premier consumer financial services company, providing credit products through partnerships with national and regional retailers, healthcare providers, and other merchants. The company operates through a single business segment managed across five sales platforms: Home & Auto, Digital, Diversified & Value, Health & Wellness, and Lifestyle.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | YTD 9M 2024 | YTD 9M 2023 |
|---|---|---|---|---|
| Net Earnings | $789 million | $628 million | $2.725 billion | $1.798 billion |
| Net Interest Income | $4.609 billion | $4.362 billion | $13.419 billion | $12.533 billion |
| Provision for Credit Losses | $1.597 billion | $1.488 billion | $5.172 billion | $4.161 billion |
| Net Charge-Off Rate (Annualized) | 6.06% | 4.60% | 6.26% | 4.62% |
| Loan Receivables (Period-End) | $102.2 billion | $97.9 billion | $102.2 billion | $97.9 billion |
| Purchase Volume | $45.0 billion | $47.0 billion | $134.2 billion | $135.8 billion |
| Deposits | $82.3 billion | $76.4 billion (Avg) | $82.3 billion | $74.8 billion (Avg) |
| Return on Equity (Annualized) | 19.8% | 18.1% | 23.8% | 17.8% |
Material Changes vs. Prior Period
- Earnings Growth: Net earnings increased 25.6% year-over-year for Q3 and 51.6% for the nine-month period. The YTD increase was significantly driven by an $802 million after-tax gain from the sale of Pets Best.
- Credit Quality Deterioration: Net charge-off rates rose sharply to 6.06% in Q3 (up 146 basis points) and 6.26% YTD (up 164 basis points), driven by lower customer payment rates. Over-30 day delinquencies increased to 4.78%.
- Revenue Drivers: Net interest income grew 5.7% in Q3 due to higher loan yields and average balances, partially offset by rising interest expense (up 18.5% in Q3) due to higher benchmark rates.
- Strategic Transactions: The company acquired Ally Lending for $2.0 billion in March 2024, adding $2.2 billion in loan receivables. It also sold Pets Best, recognizing a $1.1 billion pre-tax gain.
- Capital Actions: The company repurchased $900 million of common stock YTD and declared dividends of $0.75 per share. A new $1.0 billion share repurchase authorization was approved in April 2024.
Outlook, Risks, and Management Commentary
- CFPB Late Fee Rule: A final rule reducing credit card late fee safe harbors to $8 remains under litigation. While currently stayed, management anticipates a significant reduction in late fee income if implemented and is adjusting pricing and policies to mitigate the impact.
- Consumer Spending: Purchase volume decreased 4.3% in Q3 due to lower consumer spending and credit actions taken in response to higher default probabilities. Management expects a low single-digit decrease in purchase volume for the full year 2024.
- Liquidity and Capital: Liquidity remains strong with $19.7 billion in liquid assets. The company maintains a "well-capitalized" status under Basel III rules. Deposits represent 84% of total funding sources.
- Regulatory Environment: The company faces increased regulatory scrutiny as a large provider of consumer financial services, including new resolution plan requirements from the FDIC and potential changes to brokered deposit definitions.
Investor Verification Checklist
- Credit Loss Trajectory: Verify if the elevated net charge-off rate (6.06%) stabilizes or continues to rise in Q4, given the seasonal trends and current payment behavior.
- CFPB Rule Impact: Monitor the status of the litigation regarding the CFPB late fee rule and the effectiveness of Synchrony's pricing adjustments to offset potential revenue loss.
- Ally Lending Integration: Assess the performance of the acquired Ally Lending portfolio and its contribution to the overall loan growth and credit metrics.
- Funding Costs: Track the cost of deposits and borrowings as interest rates remain elevated, impacting the net interest margin.
- Share Repurchase Execution: Confirm the pace of the remaining $700 million share repurchase authorization under the 2024 plan.